TrialNCT05824923
A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure
- Status
- ACTIVE NOT RECRUITING
- Phase
- PHASE3
- Last update posted
- 07/21/2026
- Start
- 08/14/2023
- Sponsor
- Pulnovo Medical (Wuxi) Co., Ltd.
- Specialties
- cardiology
Conditions: Pulmonary Hypertension; Heart Failure With Reduced Ejection Fraction; Hypertension; Vascular Diseases; Cardiovascular Diseases; Heart Failure; Heart Failure With Preserved Ejection Fraction; Heart Failure With Mid Range Ejection Fraction
Brief summary
It's a phase III, prospective, multicenter, randomized controlled trial to evaluate the safety and efficacy of the pulmonary artery denervation (PADN) for heart failure (HF) patients diagnosed with pulmonary hypertension associate with left heart disease (PH-LHD) by right heart catheterization.
Protocol documents and results are not hosted here. Verify every detail on ClinicalTrials.gov.